Soleno Therapeutics (SLNO) Profit After Tax: 2013-2017
Historic Profit After Tax for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to -$4.7 million.
- Soleno Therapeutics' Profit After Tax fell 81.50% to -$4.7 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$15.4 million, marking a year-over-year decrease of 27.52%. This contributed to the annual value of -$175.9 million for FY2024, which is 351.16% down from last year.
- Latest data reveals that Soleno Therapeutics reported Profit After Tax of -$4.7 million as of Q4 2017, which was down 25.28% from -$3.8 million recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' Profit After Tax registered a high of $1.9 million during Q2 2015, and its lowest value of -$11.7 million during Q1 2015.
- Moreover, its 3-year median value for Profit After Tax was -$3.2 million (2015), whereas its average is -$3.6 million.
- Data for Soleno Therapeutics' Profit After Tax shows a peak YoY increase of 167.35% (in 2015) and a maximum YoY decrease of 1,297.00% (in 2015) over the last 5 years.
- Over the past 5 years, Soleno Therapeutics' Profit After Tax (Quarterly) stood at -$974,243 in 2013, then plummeted by 640.95% to -$7.2 million in 2014, then surged by 60.59% to -$2.8 million in 2015, then grew by 8.13% to -$2.6 million in 2016, then crashed by 81.50% to -$4.7 million in 2017.
- Its Profit After Tax was -$4.7 million in Q4 2017, compared to -$3.8 million in Q3 2017 and -$4.0 million in Q2 2017.